Search research articles
Contact Us
Filters
Showing results (101-110 of 132) with videos related to
Page
of 14
Sort By:
Clinical Epigenetics
|
June 13, 2019
DNA methylation profiling allows for characterization of atrial and ventricular cardiac tissues and hiPSC-CMs
Kirstin Hoff, Marta Lemme, Anne-Karin Kahlert, et al.
Circulation
|
September 5, 2020
An Important Role for DNMT3A-Mediated DNA Methylation in Cardiomyocyte Metabolism and Contractility
Alexandra Madsen, Grit Höppner, Julia Krause, et al.
Stem Cell Reports
|
October 14, 2020
Comparison of 10 Control hPSC Lines for Drug Screening in an Engineered Heart Tissue Format
Ingra Mannhardt, Umber Saleem, Diogo Mosqueira, et al.
Stem Cell Reports
|
May 24, 2016
Human Engineered Heart Tissue: Analysis of Contractile Force
Ingra Mannhardt, Kaja Breckwoldt, David Letuffe-Brenière, et al.
British Journal of Pharmacology
|
February 23, 2026
Higher sensitivity to ouabain-induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes than human adult heart tissue despite similar Na<sup>+</sup>/K<sup>+</sup>-ATPase pump current amplitudes
Djemail Ismaili, Paavo Virtanen, Junsoo Im, et al.
Human Molecular Genetics
|
April 12, 2013
Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity
Marie-Elodie Cattin, Anne T Bertrand, Saskia Schlossarek, et al.
European Heart Journal
|
May 10, 2018
CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy
Diogo Mosqueira, Ingra Mannhardt, Jamie R Bhagwan, et al.
Nature Protocols
|
May 12, 2017
Differentiation of cardiomyocytes and generation of human engineered heart tissue
Kaja Breckwoldt, David Letuffe-Brenière, Ingra Mannhardt, et al.
Human Molecular Genetics
|
April 24, 2012
Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy
Felix W Friedrich, Brendan R Wilding, Silke Reischmann, et al.
Nature Protocols
|
August 7, 2019
Author Correction: Differentiation of cardiomyocytes and generation of human engineered heart tissue
Kaja Breckwoldt, David Brenière-Letuffe, Ingra Mannhardt, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 132) with videos related to
Sort By:
Page
of 14
Clinical Epigenetics
|
June 13, 2019
DNA methylation profiling allows for characterization of atrial and ventricular cardiac tissues and hiPSC-CMs
Kirstin Hoff, Marta Lemme, Anne-Karin Kahlert, et al.
Circulation
|
September 5, 2020
An Important Role for DNMT3A-Mediated DNA Methylation in Cardiomyocyte Metabolism and Contractility
Alexandra Madsen, Grit Höppner, Julia Krause, et al.
Stem Cell Reports
|
October 14, 2020
Comparison of 10 Control hPSC Lines for Drug Screening in an Engineered Heart Tissue Format
Ingra Mannhardt, Umber Saleem, Diogo Mosqueira, et al.
Stem Cell Reports
|
May 24, 2016
Human Engineered Heart Tissue: Analysis of Contractile Force
Ingra Mannhardt, Kaja Breckwoldt, David Letuffe-Brenière, et al.
British Journal of Pharmacology
|
February 23, 2026
Higher sensitivity to ouabain-induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes than human adult heart tissue despite similar Na<sup>+</sup>/K<sup>+</sup>-ATPase pump current amplitudes
Djemail Ismaili, Paavo Virtanen, Junsoo Im, et al.
Human Molecular Genetics
|
April 12, 2013
Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity
Marie-Elodie Cattin, Anne T Bertrand, Saskia Schlossarek, et al.
European Heart Journal
|
May 10, 2018
CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy
Diogo Mosqueira, Ingra Mannhardt, Jamie R Bhagwan, et al.
Nature Protocols
|
May 12, 2017
Differentiation of cardiomyocytes and generation of human engineered heart tissue
Kaja Breckwoldt, David Letuffe-Brenière, Ingra Mannhardt, et al.
Human Molecular Genetics
|
April 24, 2012
Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy
Felix W Friedrich, Brendan R Wilding, Silke Reischmann, et al.
Nature Protocols
|
August 7, 2019
Author Correction: Differentiation of cardiomyocytes and generation of human engineered heart tissue
Kaja Breckwoldt, David Brenière-Letuffe, Ingra Mannhardt, et al.
Page
of 14